Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

BACKGROUND Essential hypertension is associated with impaired endothelium-dependent vasodilation. Inactivation of endothelium-derived nitric oxide by oxygen free radicals participates in endothelial dysfunction in experimental hypertension. To test this hypothesis in humans, we evaluated the effect of antioxidant vitamin C on endothelium-dependent responses in essential hypertensive patients. METHODS AND RESULTS In 14 healthy subjects (47.1+/-4.8 years; blood pressure, 120.6+/-4.5/80.9+/-3.5 mm Hg) and 14 essential hypertensive patients (47.3+/-5.1 years; blood pressure, 153.9+/-7.1/102.3+/-4.1 mm Hg), we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 microg x 100 mL(-1) x min(-1)) or sodium nitroprusside (1, 2, and 4 microg/100 mL forearm tissue per minute), an endothelium-dependent and -independent vasodilator, respectively, in basal conditions and during infusion of intrabrachial vitamin C (2.4 mg/100 mL forearm tissue per minute). In hypertensive patients but not in control subjects, vitamin C increased (P<0.01) the impaired vasodilation to acetylcholine, whereas the response to sodium nitroprusside was unaffected. Moreover, in another 14 hypertensive patients (47.1+/-5.2 years; blood pressure, 155.2+/-6.9/103.7+/-4.5 mm Hg), the facilitating effect of vitamin C on vasodilation to acetylcholine was reversed by N(G)-monomethyl-L-arginine (100 microg/100 mL forearm tissue per minute), a nitric oxide synthase inhibitor, suggesting that in essential hypertension superoxide anions impair endothelium-dependent vasodilation by nitric oxide breakdown. Finally, because in adjunctive 7 hypertensive patients (47.8+/-6.1 years; blood pressure, 155.3+/-6.8/103.5+/-4.3 mm Hg), indomethacin (50 microg/100 mL forearm tissue per minute), a cyclooxygenase inhibitor, prevented the potentiating effect of vitamin C on vasodilation to acetylcholine, it is possible that in essential hypertension a main source of superoxide anions could be the cyclooxygenase pathway. CONCLUSIONS In essential hypertensive patients, impaired endothelial vasodilation can be improved by the antioxidant vitamin C, an effect that can be reversed by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. These findings support the hypothesis that nitric oxide inactivation by oxygen free radicals contributes to endothelial dysfunction in essential hypertension.

[1]  L. Ghiadoni,et al.  Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. , 1997, Hypertension.

[2]  P. Sleight.  Primary prevention of coronary heart disease in hypertension , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[3]  M. Brown,et al.  A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) , 1996 .

[4]  H. Just,et al.  Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. , 1996, Circulation.

[5]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[6]  Janzen,et al.  The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. , 1996, The Canadian journal of cardiology.

[7]  T. Lüscher,et al.  Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. , 1996, Hypertension.

[8]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[9]  A. Dominiczak,et al.  Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. , 1995, Hypertension.

[10]  A. Quyyumi,et al.  Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. , 1995, Hypertension.

[11]  E. Ferrannini,et al.  Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. , 1995, Circulation.

[12]  L. Ghiadoni,et al.  Aging and endothelial function in normotensive subjects and patients with essential hypertension. , 1995, Circulation.

[13]  A. Quyyumi,et al.  Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. , 1995, Circulation.

[14]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[15]  A. Quyyumi,et al.  Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. , 1994, Journal of the American College of Cardiology.

[16]  F. Cosentino,et al.  Role of superoxide anions in the mediation of endothelium-dependent contractions. , 1994, Hypertension.

[17]  A. Salvetti,et al.  Vasodilation to acetylcholine in primary and secondary forms of human hypertension. , 1993, Hypertension.

[18]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[19]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[20]  A. Quyyumi,et al.  Effect of Increased Availability of Endothelium‐Derived Nitric Oxide Precursor on Endothelium‐Dependent Vascular Relaxation in Normal Subjects and in Patients With Essential Hypertension , 1993, Circulation.

[21]  A. Quyyumi,et al.  Role of Endothelium‐Derived Nitric Oxide in the Abnormal Endothelium‐Dependent Vascular Relaxation of Patients With Essential Hypertension , 1993, Circulation.

[22]  A. Hughes,et al.  Free-radical scavengers, thiol-containing reagents and endothelium-dependent relaxation in isolated rat and human resistance arteries. , 1993, Clinical science.

[23]  S. Moncada,et al.  Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. , 1992, Journal of hypertension.

[24]  J. McCord,et al.  Superoxide dismutase: pharmacological developments and applications. , 1992, Advances in pharmacology.

[25]  A. Yeung,et al.  The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.

[26]  J. Sasaki,et al.  Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. T. Shepherd,et al.  Endothelium‐Derived Vasoactive Factors: II Endothelium‐Dependent Contraction , 1991, Hypertension.

[28]  D. Harrison,et al.  Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. , 1991, The American journal of physiology.

[29]  Paul M. Vanhoutte,et al.  The Endothelium: Modulator of Cardiovascular Function , 1990 .

[30]  A. Quyyumi,et al.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. , 1990, The New England journal of medicine.

[31]  Z. Katušić,et al.  Thromboxane A2 Receptor Antagonists Inhibit Endothelium‐Dependent Contractions , 1990, Hypertension.

[32]  T. Lüscher,et al.  Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. , 1990, Circulation.

[33]  K. Okumura,et al.  Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. , 1990, Hypertension.

[34]  A. Yeung,et al.  Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.

[35]  加藤 敏夫.  Prostaglandin H[2] may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat , 1990 .

[36]  D. Wood,et al.  Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Men a , 1989, Annals of the New York Academy of Sciences.

[37]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[38]  B. Ames,et al.  Ascorbate is an outstanding antioxidant in human blood plasma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Z. Katušić,et al.  Superoxide anion is an endothelium-derived contracting factor. , 1989, The American journal of physiology.

[40]  E. Nabel,et al.  Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. , 1989, The Journal of clinical investigation.

[41]  S. Moncada,et al.  A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.

[42]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[43]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[44]  H. Shirahase,et al.  A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral arteries. , 1987, Blood vessels.

[45]  R. Pedrinelli,et al.  Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. , 1986, Hypertension.

[46]  P. Vanhoutte,et al.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[47]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[48]  T. Lüscher,et al.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. , 1986, Hypertension.

[49]  A. Bendich,et al.  The antioxidant role of vitamin C , 1986 .

[50]  D. Dewitt,et al.  Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. , 1985, Circulation research.

[51]  M. Lewis,et al.  Endothelium Derived Relaxant Factor , 1985, Journal of the Royal College of Physicians of London.

[52]  M. Lewis,et al.  The nature of endothelium-derived vascular relaxant factor , 1984, Nature.

[53]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[54]  I. Fridovich.  The biology of oxygen radicals. , 1978, Science.

[55]  G. Schultz,et al.  Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens , 1977, Nature.

[56]  R. J. Whitney,et al.  The measurement of volume changes in human limbs , 1953, The Journal of physiology.